News
1d
The Brighterside of News on MSNWeight-loss drug Tirzepatide significantly slows breast cancer growth, study findsKey Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
3d
MedPage Today on MSNMenopause Hormone Therapy Users May Lose More on Weight Loss InjectableSAN FRANCISCO -- Menopause hormone therapy (MHT) was tied to a weight-loss boost in postmenopausal women taking a weight loss ...
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss: Study
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, ...
For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results